At week 12 post-treatment, significant reductions were observed in the ratio of hepatic steatosis degree, CAP, LSM, the ratio of fatty liver diagnosed by upper abdominal ultrasound, WC, WHR, ALT, AST, visceral fat grade, 25 hydroxyvitamin D (25(OH)D), HbA1c, and HOMA-IR compared to baseline values (p < 0.05) in both groups. The gene discussed is GPT; the disease is fatty liver disease.